Home                                     

Primary Angioplasty Project

PIERS

New
JAMA April 17, 2002
expanded "Methods"

The Atlantic C-PORT
The Atlantic Cardiovascular Patient Outcomes Research Team

Welcome to the Atlantic C-PORT web site. 

At this site, you will find information related to the primary angioplasty registry currently underway ("C-PORT II") and the Patient Initiated Emergency Response System (PIERS).  You will also find links to related news items, links to the Maryland Medical Research Institute, MMRI, which serves as the data coordinating center for the C-PORT trial, a forum for discussion and links to other interesting cardiovascular sites.

The Atlantic C-PORT is a network of physician and nurse cardiovascular specialists, health care economists, quality of life researchers, clinical trial specialists, hospital administrators, and government health care policymakers and regulators.

The Atlantic C-PORT designs, develops and implements community-based, clinical trials in the area of cardiovascular medicine. 

C-PORT trials are characterized by

  • a wide range of hospital types involved including academic, tertiary and community
  • a wide range of practitioner styles including academic, hospital-based and office-based
  • a patient population with varied demographic characteristics representative of the U.S. population that follows from the variety of participating hospitals and practices
  • a comprehensive set of outcome measures including
    • medical
    • economic and
    • health-related quality of life
  • an independent data coordinating center, the Maryland Medical Research Institute

The C-PORT has a decentralized structure. Participants can propose and run clinical trials from any of the affiliated institutions, including and using C-PORT components appropriate for their needs.


C-PORT Trials

The Atlantic C-PORT conducts clinical cardiovascular trials involving new treatments or diagnostic methods; studies must be of significant intellectual interest. Study outcomes must lead to significant new treatments or new diagnostic tools important in cardiac care. Comprehensive comparisons of alternative "standard" treatments are of interest to the C-PORT when outcomes of such a comparison have important implications for the treatment of heart disease or development of public policy.


Contact Information

To get in touch with the Atlantic C-PORT call, fax, write or e-mail us at the numbers and addresses listed below. C-PORT Medical Director Thomas Aversano, M.D. and C-PORT Nursing Director and Study Coordinator Lynnet T. Aversano, R.N.  will be happy to speak with you and, if not available when you call, will return your call promptly.

Telephone
Dr. Aversano 410-955-3996 ....................... Mrs. Aversano  410-955-5399
 
FAX
410-955-0223
 
Postal address
Johns Hopkins Hospital, 600 N. Wolfe Street, Blalock 524, Baltimore, MD 21287
 
Pager
410-283-3660 - Dr. Aversano       410-283-3727 - Mrs. Aversano
 
 
Electronic mail
 
MAIL_SLAT.GIF (235 bytes)  Taversano@cport.org - Dr. Aversano  

MAIL_SLAT.GIF (235 bytes)
  Laversano@cport.org - Mrs. Aversano

Got To Top of Page

Last modified:  03/29/2002